WMU Biosciences Research & Commercialization Center — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
Peptinovopeptinovo.comJun 2021
Peptinovo develops a patented drug delivery platform (PALM carrier technology) intended to improve the efficacy of approved chemotherapies for a range of solid tumors while reducing serious side effects.
BiotechHealthtechAnn Arbor, US
REYNOLD HOMAN(Executive Officer, Director)BILL ELLIOTT(Executive Officer)STEVE TOKAZ(Executive Officer, Director)
BoardDAVID ROMENESCO(Director)FRED BROWN(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.